Stomach bug treatment may relieve chronic gut discomfort

NCT ID NCT07272681

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether standard treatment to eliminate H. pylori bacteria can improve ongoing stomach and gut symptoms in 100 adults. Participants will receive antibiotics and acid-reducing medication, and their symptoms will be tracked using a questionnaire. The goal is to see if successful eradication leads to meaningful symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
standard Helicobacter pylori eradication therapy (antibiotics and acid-reducing medication)
What this could lead to
If successful, this could confirm that eradicating H. pylori reliably reduces common stomach and gut symptoms, offering a clear treatment path for many patients.
What could go wrong
This is a small, early-stage study without a placebo group, so symptom improvement could be due to other factors. Eradication therapy can also cause side effects like nausea or diarrhea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSPEPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.